Sentinel node mapping in lung cancer patients using radioisotope technique

M. Fukuta, T. Tokushima, K. Nakai, N. Itou (Matsue, Yonano, Japan)

Source: Annual Congress 2002 - Isolated lung perfusion and lung cancer
Session: Isolated lung perfusion and lung cancer
Session type: Oral Presentation
Number: 1151
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

I presented this data at the ERS annual congress last year. Using the dye-guided method postoperatively, identification rate of the sentinel node (SN) was 93.4%, the accuracy was 94.7%,and it was considered that lung cancer surgery with a reduces range of the lymph node dissection was facilitated by determining the presence or absence of metastasis in the identified SN.
Based on this data we are now examining the identification of SN using the radioisotope technique intraoperatively. Though the series is still limited to 11cases, we report the method and results to date. Under CT-guidance, Tc-99 tin colloid was preoperatively injected around the tumor circumference . The activity of Tc -99 was measured intraoperatively using gamma counter, and the lymph node in which the activity was the highest was defined as SN. If lymph node metastasis was detected, it was then determined whether the defined SN was the metastatic lymph node.
The SN identification rate was 45.5%, and the accuracy was 100%. Since the identification rate was low, timing of Tc-99 injection was changed from just before surgery to the previous evening. SN were successfully identified in the resent 2 cases. Other merits of this changed is that the radioisotope that flowed into the trachea disappeared and the detection of background radiation decreased. In the future, further cases will be accumulated and a method of reducing lymph node dissection will be established.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fukuta, T. Tokushima, K. Nakai, N. Itou (Matsue, Yonano, Japan). Sentinel node mapping in lung cancer patients using radioisotope technique. Eur Respir J 2002; 20: Suppl. 38, 1151

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A study on the identification of the sentinel node in the lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 14s
Year: 2001

Evaluation of the integrated PET/CT and the EBUS-TBNA of lymph nodes in patients with suspected cancer
Source: Annual Congress 2010 - Are needles enough: the value of different approaches
Year: 2010

Role of molecular and cellular techniques applied to EBUS-TBNA of mediastinal lymph nodes for lung cancer staging
Source: Annual Congress 2012 - EBUS-TBNA: a never ending story
Year: 2012

Sampling of ipsilateral mediastinal nodes by EBUS-TBNA in lung cancer staging
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012

Microbiological study of mediastinal lymph node biopsy from patients with sarcoidosis and lung cancer
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018




Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?
Source: Eur Respir J 2007; 30: Suppl. 51, 452s
Year: 2007

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007

Probability model for malignancy in hilar and mediastinal lymph nodes in lung cancer based on PET-CT and EBUS
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019


The role of PET-CT in mediastinal lymph node staging in NSCLC
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


EBUS-TBNA of lymph nodes in the radiologically and PET normal mediastinum in patients with lung cancer
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008



Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=163
Year: 2007

Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies
Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging
Year: 2004


EBUS guided trans-bronchial lymph node cryobiopsy (EBUS-TBLNC): A novel technique for lymph node biopsy
Source: Virtual Congress 2021 – Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound
Year: 2021


Endobronchial ultrasound guided biopsy followed by real-time PCR is an applicable method to analyse SHOX2 methylation level in mediastinal lymph nodes of lung cancer patients
Source: Annual Congress 2012 - EBUS-TBNA: a never ending story
Year: 2012




Role of Tc-99m MIBI chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 314s
Year: 2005

Electromagnetic navigation for peripheral lung lesions and mediastinal lymph nodes
Source: Eur Respir Mon; 2010: 48: 256–271
Year: 2010

EBUS strain elastography for predicting lymph node malignancy: standardization of assessment technique
Source: International Congress 2019 – Use of thoracic ultrasound to diagnose lung diseases
Year: 2019


Endobronchial ultrasound for assessment of positive pet lung lymph intrathorarical node
Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer
Year: 2010